|
|
| |
|
FDA CLEARS NEW LABELING GUIDELINES FOR ALTERNATE SITE TESTING OPTION WITH LIFESCAN BLOOD GLUCOSE MONITORING PRODUCTS Milpitas, Calif., December 17, 2001 - The U.S. Food and Drug Administration has cleared blood glucose testing guidelines developed by LifeScan, Inc. for alternate site testing with three of the company's products. The new guidelines explain the proper role of alternate site blood glucose testing, a less painful alternative to traditional fingertip testing for people with diabetes 1. The guidelines also answer many of the questions about alternate site testing so that more people with diabetes can use this appealing testing option with confidence. They were developed for use with the OneTouch® Ultra and OneTouch® FastTake® Blood Glucose Monitoring Systems, and the InDuo® System, all products of LifeScan, a Johnson & Johnson company 2. In June of 2000, LifeScan made alternate site testing widely available to people with diabetes, who rely on their blood glucose test results to help them manage their disease and reduce their risk of serious complications. Alternate site testing allows the user to obtain the necessary blood sample for a glucose test from a body site other than the fingertip, which is the traditional site for a blood glucose test. In addition to fingertip testing, the three LifeScan products are cleared for alternate site testing on the forearm, which has fewer nerve endings than the fingertip and is less painful for many people. The LifeScan guidelines provide new, clinically based information 3 about when it's most appropriate to use each of the two different blood glucose testing methods. The guidelines are significant because there can be differences between glucose results obtained from tests on the fingertips and those obtained from tests on an alternate site, such as the forearm. In fact, because body tissues use glucose at different rates, it's possible for a person to test on two different parts of the body at the same point in time and get different test results. The conditions under which these differences are most likely to occur are when blood glucose levels are changing rapidly, such as following a meal, an insulin dose or physical exercise. Highlights of the new LifeScan testing guidelines point out that 4:
"We are pleased that we could work together with the FDA to develop guidelines that will help people with diabetes understand when and how to safely use this pain-saving method for blood glucose testing," said David Horwitz, M.D., Ph.D., vice president of medical and regulatory affairs for LifeScan. LifeScan, a leading maker of blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes. More diabetes specialists recommend the company's
What you should do:
|
|||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||
|
Home | Company | Products | Diabetes Care | OneTouch Gold | Professionals | Feedback | Around the World |
|
|
|
|